Abiopharma

🔍 Cheung Kenneth (Executive)

Company: Super Micro Computer, Inc. (SMCI)

Report Date: 2025-07-29

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2025-07-29 | Code: H | shares_owned_after: 59,331.00
• Acquired 30,486 shares of Employee Stock Option (right to buy) at $58.63 per share (Derivative)
  Date: 2025-07-29 | Code: A | Expires: 2035-07-29 | equity_swap_involved: 0 | shares_owned_after: 30,486.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 13,718 shares of Restricted Stock Units (Derivative)
  Date: 2025-07-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,718.00 | transaction_form_type: 4 | Footnotes: F3, F1, F4, F4

Footnotes:

• F1: This Form 4 is being filed late due to an inadvertent administrative error. The transaction reported herein occurred on July 29, 2025 and was not timely reported.
• F2: Subject to the Reporting Person's continued service to SMCI, the total number of shares subject to the option shall vest and become exercisable at the rate of 1/4th of the shares on the first anniversary of the vesting commencement date on July 29, 2026, and 1/16th at the end of each successive calendar quarter thereafter.
• F3: Each restricted stock unit represents a contingent right to receive one share of SMCI common stock.
• F4: Subject to the Reporting Person's continued service to SMCI, the restricted stock units vest at the rate of 25% of the total number of units on August 10, 2026 and 1/16th at the end of each successive calendar quarter thereafter. Vested units are settled in shares of SMCI common stock.